Please Wait
Applying Filters...
menu
    • menu
    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Jan 2026 highlights: Astra, CSPC sign up to US$ 18.5 bn obesity deal; Wegovy’s pill version debuts in US

    Stock Recap
    #PipelineProspector

    Menu

    Memantine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 516Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    19/09/2025 Alembic Pharmaceuticals Limited
    India
    		 M/s. Alembic Pharmaceuticals Limited WC-0081 Memantine Hydrochloride IH 2025-08-08 2028-07-02 API Division Panelav, At & Post. - Panelav, Tal.
    06/02/2026 Aparna Pharmaceuticals
    India
    		 M/s Aparna Pharmaceuticals Pvt ltd WC-0460 Memantine Hydrochloride USP 2024-03-21 2027-03-20 Sy. No. 78, 79, 80 & 145, Chittivalasa Village,Padibhimavaram (Panchayat), Ranastalam (M),Srikakulam District, Andhra Pradesh, India
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.